Precision

Ancora Issues Letter to Fellow Shareholders Regarding Norfolk Southern’s Failures of Diligence and Poor Judgment in Appointing John Orr as COO

Retrieved on: 
Friday, April 5, 2024

Ohio-based Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” or “we”), which owns a large equity stake in Norfolk Southern Corporation (NYSE: NSC) (“Norfolk Southern” or the “Company”), today issued the below letter to fellow shareholders regarding the Board of Directors’ (the “Board”) apparent failures of diligence and poor judgment in appointing John Orr as COO.

Key Points: 
  • Ohio-based Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” or “we”), which owns a large equity stake in Norfolk Southern Corporation (NYSE: NSC) (“Norfolk Southern” or the “Company”), today issued the below letter to fellow shareholders regarding the Board of Directors’ (the “Board”) apparent failures of diligence and poor judgment in appointing John Orr as COO.
  • Ancora is a sizable shareholder of Norfolk Southern, meaning our interests and your interests are squarely aligned.
  • The Board and Mr. Shaw provided CPKC with excessive financial and strategic consideration that weakens Norfolk Southern’s long-term competitive positioning.
  • Norfolk Southern operated from a position of desperation, and shareholders and other stakeholders now stand to pay a steep price.

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 27, 2024

PBGENE-HBV (Viral Elimination Program): Precision is developing PBGENE-HBV for the treatment of patients with chronic hepatitis B.

Key Points: 
  • PBGENE-HBV (Viral Elimination Program): Precision is developing PBGENE-HBV for the treatment of patients with chronic hepatitis B.
  • In November 2023, Precision presented preclinical efficacy and safety data at the 2023 American Association for the Study of Liver Diseases Annual Meeting.
  • Cash and Cash Equivalents: As of December 31, 2023, Precision had $116.7 million in cash and cash equivalents.
  • Revenues: Total revenues for the quarter ended December 31, 2023 were $7.0 million, as compared to $10.6 million for the quarter ended December 31, 2022.

Stryker launches Gamma4 Hip Fracture Nailing System in Europe

Retrieved on: 
Tuesday, March 26, 2024

Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.

Key Points: 
  • Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.
  • The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system.
  • The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
  • The new Gamma4 system redefines hip fracture care with sleek instrumentation, advanced nail design and improved geometry collectively, ensuring a lasting impact on orthopaedic practices for years to come.”

Elevating Societal Impact: Matter’s Precision Group Expands Client Base in Sustainability and Nonprofit Categories

Retrieved on: 
Tuesday, March 26, 2024

Matter Communications – a Brand Elevation Agency integrating PR, marketing and creative services – today announced the growth of its Precision group, a PR and content division of Matter that provides highly focused programs to support brands’ biggest business drivers, in sustainability/Greentech and nonprofit categories.

Key Points: 
  • Matter Communications – a Brand Elevation Agency integrating PR, marketing and creative services – today announced the growth of its Precision group, a PR and content division of Matter that provides highly focused programs to support brands’ biggest business drivers, in sustainability/Greentech and nonprofit categories.
  • The concerted efforts of the team represent the agency’s commitment to serving the missions of brands that actively seek to improve communities, causes and the environment of the world around us.
  • “We see the Precision team at Matter as an extension of our internal team, helping to elevate our company in key trade, business and regional media.
  • This is why Precision was built!”
    To learn more about Matter’s Precision group, please visit the Matter Precision Page .

Boulevard Launches New Capital Program Designed Specifically for Self-Care Businesses

Retrieved on: 
Wednesday, March 20, 2024

Boulevard ( www.joinblvd.com ), provider of the client experience platform purpose-built for appointment-based, self-care businesses, today announced the launch of Boulevard Capital.

Key Points: 
  • Boulevard ( www.joinblvd.com ), provider of the client experience platform purpose-built for appointment-based, self-care businesses, today announced the launch of Boulevard Capital.
  • Based on demonstrated business performance rather than credit history, Boulevard Capital offers self-care business owners the fast, flexible funding they need to reinvest in their businesses and drive continued growth.
  • “For years, the self-care industry has been underserved by lenders who understand little to nothing about how these unique businesses work,” said Matt Danna, co-founder and CEO of Boulevard.
  • Boulevard Capital addresses this challenge by providing eligible customers with fast, flexible funding to make critical investments in their businesses.

Global Medical Metal Tubing Market to Reach $1,161.9 Million, by 2030 at 7.4% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, March 26, 2024

The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.

Key Points: 
  • The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4052
    Advancements in technology, such as the development of biocompatible and antimicrobial medical metal tubing, are further propelling the growth of the medical metal tubing market.
  • Additionally, the increasing adoption of minimally invasive surgeries and the rising demand for precision medical devices are creating lucrative opportunities for the medical metal tubing market.
  • In conclusion, the medical metal tubing market is experiencing considerable growth due to the growing demand for medical metal tubing in the healthcare sector and advancements in technology driving market growth.

Global Medical Metal Tubing Market to Reach $1,161.9 Million, by 2030 at 7.4% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, March 26, 2024

The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.

Key Points: 
  • The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4052
    Advancements in technology, such as the development of biocompatible and antimicrobial medical metal tubing, are further propelling the growth of the medical metal tubing market.
  • Additionally, the increasing adoption of minimally invasive surgeries and the rising demand for precision medical devices are creating lucrative opportunities for the medical metal tubing market.
  • In conclusion, the medical metal tubing market is experiencing considerable growth due to the growing demand for medical metal tubing in the healthcare sector and advancements in technology driving market growth.

SkinPen® Precision Wins Prestigious Aesthetics Awards 2024 for "Best Energy Device of the Year"

Retrieved on: 
Thursday, March 21, 2024

This prestigious award recognizes the remarkable impact SkinPen Precision has had in advancing healthcare through cutting-edge technology and superior patient outcomes.

Key Points: 
  • This prestigious award recognizes the remarkable impact SkinPen Precision has had in advancing healthcare through cutting-edge technology and superior patient outcomes.
  • The Aesthetics Awards are the most prestigious and longest-standing awards ceremony in the UK medical aesthetics specialty.
  • Backed by over 90 clinical studies and extensive clinical data, SkinPen Precision is a game-changer in the aesthetics' landscape.
  • CE Mark – Medical Device Class IIa:
    Medical Purpose: SkinPen Precision Microneedling System is a medical device intended to treat facial acne scars in adults aged 22 years or older.

SkinPen® Precision Wins Prestigious Aesthetics Awards 2024 for "Best Energy Device of the Year"

Retrieved on: 
Thursday, March 21, 2024

This prestigious award recognizes the remarkable impact SkinPen Precision has had in advancing healthcare through cutting-edge technology and superior patient outcomes.

Key Points: 
  • This prestigious award recognizes the remarkable impact SkinPen Precision has had in advancing healthcare through cutting-edge technology and superior patient outcomes.
  • The Aesthetics Awards are the most prestigious and longest-standing awards ceremony in the UK medical aesthetics specialty.
  • Backed by over 90 clinical studies and extensive clinical data, SkinPen Precision is a game-changer in the aesthetics' landscape.
  • CE Mark – Medical Device Class IIa:
    Medical Purpose: SkinPen Precision Microneedling System is a medical device intended to treat facial acne scars in adults aged 22 years or older.

Norfolk Southern appoints industry veteran John Orr as chief operating officer

Retrieved on: 
Wednesday, March 20, 2024

ATLANTA, March 20, 2024 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) announced Wednesday the appointment of John Orr as executive vice president and chief operating officer, effective immediately. Throughout his four-decade career, Orr has earned a reputation as a proven leader in applying scheduled railroading principles to drive sustainable long-term value creation. He spearheaded the turnaround of Canadian Pacific Kansas City's (CPKC) Mexico operations by successfully implementing a high-efficiency operating model, shaped and guided the execution of Kansas City Southern's (KCS) service-focused scheduled railroading initiatives, and drove significant improvements in Canadian National Railway's (CN) safety and operational performance.

Key Points: 
  • ATLANTA, March 20, 2024 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) announced Wednesday the appointment of John Orr as executive vice president and chief operating officer, effective immediately.
  • He will report directly to Norfolk Southern president and chief executive officer Alan H. Shaw.
  • In connection with Orr's appointment, current chief operating officer Paul Duncan departed the company to pursue other opportunities.
  • Alan Shaw, Norfolk Southern president and chief executive officer, said, "John is a deeply respected and accomplished leader, and is the right chief operating officer to ensure execution of our strategy of balancing safe service, productivity, and growth.